ArticleHeliyon2018

IL-33 suppresses GSK-3β activation through an ST2-independent MyD88/TRAF6/RIP/PI3K/Akt pathway.

Tomoyuki NishizakiPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.